For the quarter ending 2026-03-31, EOLS had -$4,034K decrease in cash & cash equivalents over the period. -$10,367K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -10,674 | 130 | -15,737 | -36,034 |
| Depreciation and amortization | 2,346 | 2,254 | 1,951 | 3,301 |
| Stock-based compensation | 5,116 | 5,147 | 5,135 | 10,416 |
| Provision for bad debts | - | - | 2,210 | 1,754 |
| Provision for credit losses and inventory | 427 | 6,515 | - | - |
| Amortization of operating lease right-of-use assets | 343 | 335 | 330 | 572 |
| Amortization of debt discount and issuance costs | 361 | 343 | 336 | 610 |
| Deferred income taxes | -5 | 27 | -21 | 15 |
| Revaluation of contingent royalty obligation payable to evolus founders | -14 | -4,511 | -107 | -1,763 |
| Non-cash in-process research and development expense | - | 0 | - | - |
| Other adjustments to operating activities | 125 | 236 | 251 | 480 |
| Inventories | -6,378 | -4,659 | 11,492 | 4,291 |
| Accounts receivable | -2,154 | 4,792 | 4,936 | 1,781 |
| Prepaid expenses | 873 | -900 | -188 | 1,443 |
| Accounts payable | -7,609 | 2,046 | 4,112 | 3,945 |
| Accrued expenses | -3,744 | 3,954 | 2,517 | -12,835 |
| Accrued litigation settlement | - | 0 | - | - |
| Operating lease liabilities | -411 | -212 | -290 | -256 |
| Other operating assets | 3,872 | 240 | -884 | 3,113 |
| Net cash used in operating activities | -9,952 | 12,827 | -14,669 | -40,423 |
| Purchases of property and equipment | 415 | 1,479 | 955 | 1,007 |
| Additions to capitalized software | 1,276 | 687 | 1,203 | 3,121 |
| Proceeds from issuance and modification of debt instruments | - | 0 | 0 | 25,000 |
| Net cash used in investing activities | -1,691 | -2,166 | -2,158 | -4,128 |
| Payment of contingent royalty obligation to evolus founders | 1,893 | 0 | 1,786 | 4,416 |
| Payments for debt modification fees and costs | - | - | 0 | 2,610 |
| Payments for debt modification fees and debt issuance costs | - | 2,610 | - | - |
| Proceeds from follow-on offering | - | 0 | 0 | 0 |
| Proceeds from issuance of debt instruments | 10,000 | - | - | - |
| Payments for offering costs | - | 0 | 0 | 0 |
| Payments for debt issuance costs | 484 | - | - | - |
| Issuance of common stock in connection with incentive equity plan | 0 | 81 | 18 | 1,065 |
| Payment of finance lease obligations | 4 | 4 | 4 | 7 |
| Tax withholding paid on behalf of employees for net share settlement | 0 | 0 | - | - |
| Net cash provided by (used in) financing activities | 7,619 | 77 | -1,772 | 19,032 |
| Effect of exchange rates on cash and cash equivalents | -10 | -435 | 384 | 305 |
| Net decrease in cash and cash equivalents | -4,034 | 10,303 | -18,215 | -25,214 |
| Cash and cash equivalents, beginning of period | 53,826 | 43,523 | 86,952 | - |
| Cash and cash equivalents, end of period | 49,792 | 53,826 | 43,523 | - |
Evolus, Inc. (EOLS)
Evolus, Inc. (EOLS)